Ambalal Sarabhai Enterprises’ subsidiary -- Asence Pharma has commenced its new oncology and synthetic API plant at Ranoli, Vadodara. The new API plant is set up to meet all domestic and international regulatory standards and will manufacture niche molecules that have a global requirement.
Asence Pharma specializes in the supply of quality pharmaceutical preparations (Bulk Drugs and Formulations) to domestic and international markets. Asence through its operations in India and USA, markets and distributes pharmaceutical preparations worldwide and has more than 100 registered products internationally with an impressive pipeline and capability for development of new medicines.
Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.
